Brief: NextCell Pharma's Chairman Resigns Due To Health Reasons
April 19 (Reuters) - NextCell Pharma AB NXTCL.ST :
* ANDERS ESSEN-MÖLLER RESIGNS AS CHAIRMAN OF NEXTCELL'S
BOARD OF
DIRECTORS DUE TO HEALTH REASONS
* ANDERS ESSEN-MÖLLER TO STEP DOWN ON 20 MAY 2024
* HANS-PETER EKRE WILL BE ACTING CHAIRMAN OF BOARD UNTIL NEW
ORDINARY CHAIRMAN CAN BE APPOINTED
Source text for Eikon: ID:nWkrcc2bHk
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln